The determination of Zinc in seminal plasma, together with the reagent for Citrate and Fructose complete the Biosystems line for the diagnostic evaluation of human fertility. Zinc is used as a marker of the secretory function of the prostate gland. Low values indicate an abnormal disruption of the secretory function, possibly as a result of obstruction of the conducts due to acute or chronic inflammation. The determination of zinc in serum provides information about the metabolism of proteins and nucleic acids, and the functioning of the immune system, which is required for wound healing. A severe blood zinc deficiency is linked with depressed growth and stunting and increases the incidence of infectious diseases. Less severe zinc deficiencies are linked with immune function disorder, diarrhea, altered cognition, alopecia, vision defects and other adverse clinical conditions. Ingestion of a zinc-contaminated diet involves high blood concentrations and is associated with abdominal pain, diarrhea and nausea. Heparinized plasma samples are preferred to serum for zinc analysis to avoid possible zinc contamination from erythrocytes, platelets and leukocytes during clotting and centrifugation.
Read more

Entirely of human origin for in vitro cell culture applications, Lysex enables selection, expansion and differentiation of human primary cell cultures, such as adult and fetal mesenchymal stem cells (MSC), skin fibroblasts, articular chondrocytes, osteoblasts, adipose-derived cells. It enhances cell proliferation, maintaining the differentiation potential in cells otherwise difficult to expand in culture such as articular chondrocytes from elderly donors and allows culture of cells in a xeno-free environment (as it completely eliminates the need of fetal bovine serum). The fully standardized and lyophilized two-component system allows easy optimization of culture conditions for any cell type directly by the user.
Read more

The Randox Homocysteine assay offers laboratories a convenient two-part, liquid ready-to-use option for the accurate determination of Homocysteine concentrations in serum or plasma.  Additional benefits associated with Randox Homocysteine include two levels of calibrator included in the kit for user convenience; limited interference helping ensure accurate and reliable results are returned; and an extensive measuring range of 1.74-47.9 µmol/l facilitating comfortable detection of abnormal levels related to all Homocysteine associated disease states. Furthermore, Randox Homocysteine is suitable for use on a variety of clinical chemistry analyzers via a range of instrument specific applications.

For more information click here
Read more

The new Coapresta 2000 (CP2000) is an automated system with a small footprint, high-throughput and a range of dedicated barcoded reagents.  The system can run up to 400 PT tests per hour. Test panels include PT, APTT, Fibrinogen, D-dimer, FDP, AT and many other new assays are in development. The system offers excellent performance, predominately ready-to-use liquid reagents,  and can be interfaced to LAS systems using point- in-space sampling, which make it an exciting new choice for laboratories seeking an efficient, high performing coagulation solution. The system is the market leading product in the higher volume system category in Japan, where it was developed. The CP2000 Coagulation System is available for purchase in Europe, Middle East and Africa through the Sekisui Diagnostics offices in Kent, UK and Rüsselsheim, Germany as of January 2014.  
Read more

The ESC, ACCF, AHA and WHF stipulate that Troponin assays should demonstrate a coefficient of variation (CV) of 10% or less at the 99th percentile of the normal population, which no prior POC device could do. The high sensitivity Meritas test achieves a CV of 10% at 36pg/ml which is the 99th percentile. Results are available patient-side within 15 minutes and the Meritas analyser uses only a single drop of whole blood in a one-step process. This test will, for the first time, allow doctors to evaluate potential MI patients quickly and accurately. With CE marking achieved, Trinity Biotech now intends to release the product for sale in Europe and other carefully selected markets through its specialist cardiology distributor network.
Read more